Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | ATR | Q13535 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Morpholine SCHEMBL702116 | 0.89 | MEN1 (0.55) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL497396 | 0.89 | MEN1 (0.55) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL10425540 | 0.87 | MEN1 (0.52) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL29191392 | 0.87 | MEN1 (0.52) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL8009459 | 0.84 | — | — | |
| Morpholine SCHEMBL2520893 | 0.82 | KDM4E (0.61) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL7554037 | 0.82 | MEN1 (0.61) | MEN1KMT2AKDM4EGAACYP2C9 | |
| Morpholine SCHEMBL8004690 | 0.81 | — | — | |
| Morpholine SCHEMBL28322795 | 0.81 | — | — | |
| Morpholine SCHEMBL7996463 | 0.80 | MEN1 (0.92) | MEN1KMT2AKDM4EGAACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2867319-A1 | ACCELERATORS FOR TWO STEP ADHESIVE SYSTEMS | Henkel US IP LLC (US) | 2015-05-06 | — | — | EP | disclosed |
| WO-2014004311-A1 | ACCELERATORS FOR TWO STEP ADHESIVE SYSTEMS | Henkel US IP LLC (US) | 2014-01-03 | — | — | WO | disclosed |
| CN-102548976-A | (Thio) morpholine derivatives as S1P modulators | ABBOTT HEALTHCARE PRODUCTS BV | 2012-07-04 | — | — | CN | disclosed |
| EP-0979208-A4 | COMPOSITION AND METHOD FOR REDUCING COPPER OXIDE TO METALLIC COPPER | MORTON INT INC (US) | 2000-10-25 | — | — | EP | disclosed |
| EP-0979208-A1 | COMPOSITION AND METHOD FOR REDUCING COPPER OXIDE TO METALLIC COPPER | MORTON INTERNATIONAL, INC. (US) | 2000-02-16 | — | — | EP | disclosed |
| EP-0938447-A1 | COMPOSITION AND METHOD FOR REDUCING COPPER OXIDE TO METALLIC COPPER | MORTON INTERNATIONAL, INC. (US) | 1999-09-01 | — | — | EP | disclosed |
| EP-0938447-A4 | — | — | 1999-09-01 | — | — | EP | disclosed |
| WO-1999042402-A1 | COMPOSITION AND METHOD FOR REDUCING COPPER OXIDE TO METALLIC COPPER | MORTON INTERNATIONAL, INC. (US) | 1999-08-26 | — | — | WO | disclosed |
| CN-1220645-A | Composition and method for reducing copper oxide to metallic copper | MORTON INT INC (US) | 1999-06-23 | — | — | CN | disclosed |
| WO-1999002452-A1 | COMPOSITION AND METHOD FOR REDUCING COPPER OXIDE TO METALLIC COPPER | MORTON INTERNATIONAL, INC. (US) | 1999-01-21 | — | — | WO | disclosed |